Literature DB >> 25126809

Clearing lactate is clearly better…but how much?*.

Michael A Puskarich1, Alan E Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25126809      PMCID: PMC4596229          DOI: 10.1097/CCM.0000000000000455

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

Review 1.  Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis*.

Authors:  Zhongheng Zhang; Xiao Xu
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

2.  Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial.

Authors:  Alan E Jones; Nathan I Shapiro; Stephen Trzeciak; Ryan C Arnold; Heather A Claremont; Jeffrey A Kline
Journal:  JAMA       Date:  2010-02-24       Impact factor: 56.272

3.  Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock.

Authors:  Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Andrew B Albers; Alan C Heffner; Jeffrey A Kline; Alan E Jones
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

4.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial.

Authors:  Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

  4 in total
  1 in total

1.  The effect of low central venous pressure on hepatic surgical field bleeding and serum lactate in patients undergoing partial hepatectomy: a prospective randomized controlled trial.

Authors:  Ling Yu; Hongwei Sun; Huangmo Jin; Hongyu Tan
Journal:  BMC Surg       Date:  2020-02-04       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.